Success Story: Reengineering Cancer Drug Discovery with Functional Genomics: NIW Approved for a United Arab Emirates Cancer Researcher

Posted by wegreened on June 17, 2026 in NIW, Medical (Gastroenterology, Cancer, Cancer Pharmacology, Cardiology, Immunology, Pathology, Hematology, Neurology, Neuroscience, Urology, Gynecology, Dentistry, Endocrinology)

On April 23^rd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the field of Cancer Research (Approval Notice).

General Field: Cancer Research

Position at the Time of Case Filing: Postdoctoral Scholar

Country of Origin: United Arab Emirates

State of Residence at the Time of Filing: Illinois

Approval Notice Date: April 23^rd, 2026

Processing Time: 2 years, 2 months (Premium Processing Requested)

Case Summary:

Cancer therapies often fail because tumors evolve, reroute signaling pathways, and develop resistance to standard regimens. In this case, the petition positioned the client’s proposed endeavor around using molecular biology and functional genomics to make cancer drug discovery more precise, so treatments can be better targeted to the mechanisms driving a patient’s disease. At the time of filing, the client was conducting cancer research in the United States as a postdoctoral scholar and planned to continue advancing this work through ongoing research and publication.

Research with National Importance

The NIW strategy emphasized that improving cancer drug discovery is not only a scientific objective but also a public health priority, because more personalized targeting can reduce treatment failure and limit the harms of broadly acting therapies. The filing framed the endeavor as nationally important by showing that scalable, evidence-based approaches to identifying drug targets and resistance mechanisms can strengthen treatment development and improve patient outcomes in the United States.

Academic Contributions and Recognition

To show the client was well-positioned, the petition documented an objective record of peer-validated output and independent reliance. At the time of filing, the client had authored 8 peer-reviewed journal articles, including 6 first-authored papers, and the overall publication record had received 114 citations. The filing also highlighted field- and year-normalized citation performance, noting that at least two papers ranked among the top 20 percent most cited in their category for their publication years, reinforcing influence beyond raw totals. Professional trust was additionally supported by an invited peer-review record, with at least one completed review for an authoritative venue.

NIW Approval and Outlook

The I-140 NIW petition was filed on February 23rd, 2024, and approved on April 23rd, 2026, following a Premium Processing upgrade after filing. The approval reflects a cohesive NIW showing that the endeavor carried substantial merit and national importance and that the client was well-positioned through a focused, technically grounded research plan supported by peer-reviewed publications, independent citation reliance, and selective peer trust indicators.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%